These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 20845310)

  • 1. Genetic polymorphisms of cytochrome P450 enzymes 2C9 and 2C19 in a healthy Mongolian population in China.
    Yang ZF; Cui HW; Hasi T; Jia SQ; Gong ML; Su XL
    Genet Mol Res; 2010 Sep; 9(3):1844-51. PubMed ID: 20845310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic polymorphisms of cytochrome P450 enzymes 2C9 and 2C19 in a healthy Iranian population.
    Zand N; Tajik N; Moghaddam AS; Milanian I
    Clin Exp Pharmacol Physiol; 2007; 34(1-2):102-5. PubMed ID: 17201743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allele and genotype frequencies of CYP2C9, CYP2C19 and CYP2D6 in an Italian population.
    Scordo MG; Caputi AP; D'Arrigo C; Fava G; Spina E
    Pharmacol Res; 2004 Aug; 50(2):195-200. PubMed ID: 15177309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic polymorphism of CYP2C9 and CYP2C19 in a Bolivian population: an investigative and comparative study.
    Bravo-Villalta HV; Yamamoto K; Nakamura K; Bayá A; Okada Y; Horiuchi R
    Eur J Clin Pharmacol; 2005 May; 61(3):179-84. PubMed ID: 15776277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic polymorphisms of CYP2C9 and CYP2C19 in the Beninese and Belgian populations.
    Allabi AC; Gala JL; Desager JP; Heusterspreute M; Horsmans Y
    Br J Clin Pharmacol; 2003 Dec; 56(6):653-7. PubMed ID: 14616425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CYP2C9 and CYP2C19 genetic polymorphisms: frequencies in the south Indian population.
    Jose R; Chandrasekaran A; Sam SS; Gerard N; Chanolean S; Abraham BK; Satyanarayanamoorthy K; Peter A; Rajagopal K
    Fundam Clin Pharmacol; 2005 Feb; 19(1):101-5. PubMed ID: 15660966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic polymorphisms of drug-metabolizing phase I enzymes CYP3A4, CYP2C9, CYP2C19 and CYP2D6 in Han, Uighur, Hui and Mongolian Chinese populations.
    Zuo J; Xia D; Jia L; Guo T
    Pharmazie; 2012 Jul; 67(7):639-44. PubMed ID: 22888523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigation of allele and genotype frequencies of CYP2C9, CYP2C19 and VKORC1 in Iran.
    Azarpira N; Namazi S; Hendijani F; Banan M; Darai M
    Pharmacol Rep; 2010; 62(4):740-6. PubMed ID: 20885015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic polymorphisms of cytochromes P450: CYP2C9, CYP2C19, and CYP2D6 in Croatian population.
    Bozina N; Granić P; Lalić Z; Tramisak I; Lovrić M; Stavljenić-Rukavina A
    Croat Med J; 2003 Aug; 44(4):425-8. PubMed ID: 12950145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic Polymorphism of Drug-Metabolizing Enzymes CYP2C9 and CYP2C19 in Moroccan Population.
    Afilal D; Basselam MA; Brakez Z; Chouham S; Brehm A; Izaabel EH
    Genet Test Mol Biomarkers; 2017 May; 21(5):298-304. PubMed ID: 28282224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic polymorphisms of drug-metabolizing enzymes CYP2D6, CYP2C9, CYP2C19 and CYP3A5 in the Greek population.
    Arvanitidis K; Ragia G; Iordanidou M; Kyriaki S; Xanthi A; Tavridou A; Manolopoulos VG
    Fundam Clin Pharmacol; 2007 Aug; 21(4):419-26. PubMed ID: 17635181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allele and genotype frequencies of polymorphic cytochromes P450 (CYP2C9, CYP2C19, CYP2E1) and dihydropyrimidine dehydrogenase (DPYD) in the Egyptian population.
    Hamdy SI; Hiratsuka M; Narahara K; El-Enany M; Moursi N; Ahmed MS; Mizugaki M
    Br J Clin Pharmacol; 2002 Jun; 53(6):596-603. PubMed ID: 12047484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allele and genotype frequencies of the polymorphic cytochrome P450 genes (CYP1A1, CYP3A4, CYP3A5, CYP2C9 and CYP2C19) in the Jordanian population.
    Yousef AM; Bulatova NR; Newman W; Hakooz N; Ismail S; Qusa H; Zahran F; Anwar Ababneh N; Hasan F; Zaloom I; Khayat G; Al-Zmili R; Naffa R; Al-Diab O
    Mol Biol Rep; 2012 Oct; 39(10):9423-33. PubMed ID: 22722998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of the most common CYP2C9 and CYP2C19 allelic variants in the population from the Republic of Macedonia.
    Jakovski K; Nestorovska AK; Labacevski N; Dimovski AJ
    Pharmazie; 2013 Nov; 68(11):893-8. PubMed ID: 24380239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences in genotype and allele frequency distributions of polymorphic drug metabolizing enzymes CYP2C19 and CYP2D6 in mainland Chinese Mongolian, Hui and Han populations.
    Yin SJ; Ni YB; Wang SM; Wang X; Lou YQ; Zhang GL
    J Clin Pharm Ther; 2012 Jun; 37(3):364-9. PubMed ID: 21913948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allele and genotype frequencies of CYP2C9 within an Iranian population (Mazandaran).
    Hashemi-Soteh SM; Shahabi-Majd N; Gholizadeh AR; Shiran MR
    Genet Test Mol Biomarkers; 2012 Jul; 16(7):817-21. PubMed ID: 22288731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic polymorphisms of CYP2C9 and CYP2C19 are not related to drug-induced idiosyncratic liver injury (DILI).
    Pachkoria K; Lucena MI; Ruiz-Cabello F; Crespo E; Cabello MR; Andrade RJ;
    Br J Pharmacol; 2007 Mar; 150(6):808-15. PubMed ID: 17279092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymorphisms of drug-metabolizing enzymes CYP2C9, CYP2C19, CYP2D6, CYP1A1, NAT2 and of P-glycoprotein in a Russian population.
    Gaikovitch EA; Cascorbi I; Mrozikiewicz PM; Brockmöller J; Frötschl R; Köpke K; Gerloff T; Chernov JN; Roots I
    Eur J Clin Pharmacol; 2003 Aug; 59(4):303-12. PubMed ID: 12879168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Association between genetic polymorphisms of CYP2C19 and CYP2C9 and phenytoin serum concentration].
    Huang Y; Yang JF; Qi XL; Wang YQ; Wang WZ; Chen B
    Zhonghua Yi Xue Za Zhi; 2004 Oct; 84(20):1686-9. PubMed ID: 15569425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CYP2C9, CYP2C19 and CYP2D6 allele frequencies in the Ashkenazi Jewish population.
    Scott SA; Edelmann L; Kornreich R; Erazo M; Desnick RJ
    Pharmacogenomics; 2007 Jul; 8(7):721-30. PubMed ID: 18240905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.